Breaking News, Promotions & Moves

Epizyme Appoints Chief Development Officer

Ho to lead clinical development, regulatory and translational medicine functions

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Peter Ho, M.D., Ph.D., has been named chief development officer at Epizyme, Inc., and Michael Shih, J.D. has been named vice president, business development.   Dr. Ho will lead Epizyme’s clinical development, regulatory and translational medicine functions. He previously held positions with Johnson & Johnson, GlaxoSmithKline, DuPont Pharma and Novartis, and has successfully led teams and guided therapeutic development from Phase I through Phase III. Dr. Ho’s development experience includes G...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters